Weinstein Boaz

10% Ownerabrdn Life Sciences Investors (HQL) · full profile →Form 4 · filed May 10, 2024
Net Buying
Open-Market Buys
$390K
Open-Market Sells
$0
Net Open-Market Flow
$390K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 9, 2024Buy(P)17K$13.80$240K3.2M
May 8, 2024Buy(P)11K$13.70$151K3.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001510281-24-000289) within minutes of acceptance. Every field above traces to the original document. Verify it directly: